TD Cowen analyst Joshua Jennings lowered the firm’s price target on Outset Medical (OM) to $15 from $25 and keeps a Buy rating on the shares. The firm lower its target to reflect slightly slower-than-expected progress in the ongoing turnaround.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OM: